BNP Paribas Financial Markets’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,792
| Closed | -$325K | – | 4574 |
|
|
2019
Q3 | $325K | Sell |
4,792
-2,748
| -36% | -$189K | ﹤0.01% | 2460 |
|
|
2019
Q2 | $439K | Buy |
7,540
+2,648
| +54% | +$157K | ﹤0.01% | 2077 |
|
|
2019
Q1 | $343K | Buy |
4,892
+4,271
| +688% | +$317K | ﹤0.01% | 2347 |
|
|
2018
Q4 | $40K | Sell |
621
-31,933
| -98% | -$2.24M | ﹤0.01% | 2826 |
|
|
2018
Q3 | $2.29M | Buy |
32,554
+31,493
| +2,968% | +$1.84M | ﹤0.01% | 1438 |
|
|
2018
Q2 | $53.5K | Sell |
1,061
-3,212
| -75% | -$127K | ﹤0.01% | 3091 |
|
|
2018
Q1 | $134K | Buy |
4,273
+117
| +3% | +$3.88K | ﹤0.01% | 3044 |
|
|
2017
Q4 | $142K | Buy |
4,156
+1,891
| +83% | +$60.3K | ﹤0.01% | 3129 |
|
|
2017
Q3 | $72.7K | Sell |
2,265
-131
| -5% | -$4.13K | ﹤0.01% | 2952 |
|
|
2017
Q2 | $78K | Buy |
2,396
+1,539
| +180% | +$48.7K | ﹤0.01% | 2944 |
|
|
2017
Q1 | $27K | Sell |
857
-952
| -53% | -$28.2K | ﹤0.01% | 2939 |
|
|
2016
Q4 | $53.2K | Sell |
1,809
-343
| -16% | -$10.5K | ﹤0.01% | 2807 |
|
|
2016
Q3 | $62.2K | Buy |
2,152
+867
| +67% | +$24.2K | ﹤0.01% | 2335 |
|
|
2016
Q2 | $33.3K | Buy |
1,285
+1,083
| +536% | +$28.8K | ﹤0.01% | 2427 |
|
|
2016
Q1 | $5K | Sell |
202
-4,584
| -96% | -$126K | ﹤0.01% | 2281 |
|
|
2015
Q4 | $168K | Buy |
4,786
+225
| +5% | +$6.03K | ﹤0.01% | 2046 |
|
|
2015
Q3 | $96.5K | Buy |
4,561
+2,655
| +139% | +$68.4K | ﹤0.01% | 2420 |
|
|
2015
Q2 | $53K | Buy |
1,906
+1,511
| +383% | +$42.6K | ﹤0.01% | 2461 |
|
|
2015
Q1 | $12.1K | Buy |
+395
| New | +$12.6K | ﹤0.01% | 2637 |
|
|
2014
Q4 | – | Sell |
-990
| Closed | -$28K | – | 3592 |
|
|
2014
Q3 | $28K | Buy |
990
+801
| +424% | +$22.3K | ﹤0.01% | 2936 |
|
|
2014
Q2 | $5.18K | Buy |
+189
| New | +$5.03K | ﹤0.01% | 2565 |
|
|
2014
Q1 | – | Sell |
-216
| Closed | -$6.32K | – | 3985 |
|
|
2013
Q4 | $6.32K | Sell |
216
-17,286
| -99% | -$549K | ﹤0.01% | 2948 |
|
|
2013
Q3 | $535K | Sell |
17,502
-1,142
| -6% | -$38.2K | ﹤0.01% | 1494 |
|
|
2013
Q2 | $591K | Buy |
+18,644
| New | +$612K | ﹤0.01% | 1400 |
|
BNP Paribas Financial Markets's GHDX Position: Q4 2019 in Review
BNP Paribas Financial Markets sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,792 shares — an estimated $325K sold.
BNP Paribas Financial Markets first reported a position in GHDX in Q2 2013 and held it in 24 quarters. The position peaked at $2.29M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- BNP Paribas Financial Markets reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 4,792 Genomic Health, Inc. shares in Q4 2019, an estimated $325K.
- BNP Paribas Financial Markets first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 24 quarters.
- BNP Paribas Financial Markets's Genomic Health, Inc. position peaked at $2.29M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.